Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7783)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 14, 2021 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee BM, Seong J. Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma. World J Gastroenterol 2021; 27(10): 919-927 [PMID: 33776363 DOI: 10.3748/wjg.v27.i10.919] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i10/919.htm |
| Number | Citing Articles |
| 1 |
Lele Miao, Zhengchao Zhang, Zhijian Ren, Yumin Li. Application of Immunotherapy in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.699060
|
| 2 |
Sibin Zhang, Xu Xiao, Yu Wang, Tianjun Song, Chenlong Li, Hongbo Bao, Qing Liu, Guiyin Sun, Xiaoyang Sun, Tianqi Su, Tianjiao Fu, Yujie Wang, Peng Liang. Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.899125
|
| 3 |
Seo Hee Choi, Byung min Lee, Jina Kim, Do Young Kim, Jinsil Seong. Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study. Journal of Hepatology 2024; 81(1): 84 doi: 10.1016/j.jhep.2024.03.003
|
| 4 |
Jian-Xu Li, Mei-Ling He, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Jian-Hong Zhong, Rui-Jun Zhang, Chun-Feng Liang, Ya-Dan Pang, Jun-Kun He, Qian-Qian Chen, Jin-Xia Weng, Shi-Xiong Liang, Bang-De Xiang. Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02596-0
|
| 5 |
Hwa Kyung Byun, Changhwan Kim, Jinsil Seong. Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma. Clinical and Molecular Hepatology 2023; 29(4): 945 doi: 10.3350/cmh.2023.0217
|
| 6 |
Jung Wan Choe, Hye Yoon Lee, Chai Hong Rim. Will the collaboration of surgery and external radiotherapy open new avenues for hepatocellular carcinoma with portal vein thrombosis?. World Journal of Gastroenterology 2022; 28(7): 704-714 doi: 10.3748/wjg.v28.i7.704
|
| 7 |
Romain Donne, Amaia Lujambio. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology 2023; 77(5): 1773 doi: 10.1002/hep.32740
|
| 8 |
Jing Liang, Yi Bai, Fu-Shuang Ha, Ying Luo, Hui-Ting Deng, Ying-Tang Gao. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(1): 1-18 doi: 10.4251/wjgo.v15.i1.1
|
| 9 |
Jiaqi Nie, Xue Qin, Xiang Tao, Jin Huang. Exploring the molecular landscape of lymphocyte activation gene-3: A literature review. Medicine 2024; 103(39): e39622 doi: 10.1097/MD.0000000000039622
|
| 10 |
Suresh Gopi Kalathil, Yasmin Thanavala. Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches. Cells 2021; 10(6): 1332 doi: 10.3390/cells10061332
|
| 11 |
Faezeh Sharafi, Sadegh Abaei Hasani, Samira Alesaeidi, Mohammad Saeed Kahrizi, Ali Adili, Shadi Ghoreishizadeh, Navid Shomali, Rozita Tamjidifar, Ramin Aslaminabad, Morteza Akbari. A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02682-z
|
| 12 |
Fatemeh Eskandari-Malayeri, Marzieh Rezaei. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.996145
|
| 13 |
Yonghua Zhu, Huabing Tan, Jincheng Wang, Haiwen Zhuang, Huanbin Zhao, Xiaojie Lu. Molecular insight into T cell exhaustion in hepatocellular carcinoma. Pharmacological Research 2024; 203: 107161 doi: 10.1016/j.phrs.2024.107161
|
| 14 |
Nalee Kim, Jason Chia-Hsien Cheng, Nitin Ohri, Wen-Yen Huang, Tomoki Kimura, Zhao Chong Zeng, Victor Ho Fun Lee, Chul Seung Kay, Jinsil Seong. Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study. Journal of Hepatocellular Carcinoma 2022; : 707 doi: 10.2147/JHC.S377810
|